Connect Biopharma Holdings Growth Metrics (2024-2025) | CNTB

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -16.32%-20.48%-31.39%
Assets (QoQ) -8.49%-10.75%-18.57%
Capital Expenditures Growth (1y) 4.48%-76.87%
Capital Expenditures (QoQ) -49.31%112.93%-74.12%274.07%-88.78%
Cash & Equivalents Growth (1y) 35.00%-25.96%-63.12%
Cash & Equivalents (QoQ) -39.02%-14.83%-6.86%
Cash from Investing Activities Growth (1y) -323.15%59.78%9,859.18%
Cash from Investing Activities (QoQ) -65.30%-104.58%-10,623.81%-30.94%124.85%179.70%
Cash from Operations Growth (1y) -1,585.11%-63.63%-33.82%
Cash from Operations (QoQ) -1,202.03%-69.03%82.17%-329.45%-26.43%-38.24%
EBITDA Margin Growth (1y) -10.59M
EBITDA Margin (QoQ) -0.04M-8.05M
EBIT Growth (1y) 9.39%-198.37%-27.67%
EBIT Margin Growth (1y) -10.93M
EBIT Margin (QoQ) -0.02M-8.25M
EBIT (QoQ) 208.02%-201.47%30.53%-19.00%-17.27%-31.68%
EBT Growth (1y) -17.95%-186.33%-33.70%
EBT Margin Growth (1y) -10.61M
EBT Margin (QoQ) -0.02M-8.04M
EBT (QoQ) 271.73%-186.17%31.35%-16.11%-25.70%-33.44%
Enterprise Value Growth (1y) -35.00%20.77%34.86%
Enterprise Value (QoQ) 10.37%14.57%23.67%
EPS (Basic) Growth (1y) -18.75%-185.19%-34.78%
EPS (Basic) (QoQ) 268.75%-185.19%29.87%-17.79%-21.05%-34.78%
EPS (Weighted Average and Diluted) Growth (1y) -18.75%-185.19%-34.78%
EPS (Weighted Average and Diluted) (QoQ) 268.75%-185.19%29.87%-17.79%-21.05%-34.78%
FCF Margin Growth (1y) -10.79M
FCF Margin (QoQ) 0.07M-8.21M
Free Cash Flow Growth (1y) -1,598.82%-61.48%-32.58%
Free Cash Flow (QoQ) -1,251.10%-64.73%79.99%-281.46%-28.43%-35.26%
Net Cash Flow Growth (1y) -453.37%-67.30%78.37%
Net Cash Flow (QoQ) -150.40%-201.42%-36.67%-70.21%76.14%61.03%
Net Income Growth (1y) -18.16%-186.88%-33.58%
Net Income (QoQ) 270.79%-186.72%30.83%-15.34%-25.57%-33.34%
Net Income towards Common Stockholders Growth (1y) -18.16%-186.88%-33.58%
Net Income towards Common Stockholders (QoQ) 270.79%-186.72%30.83%-15.34%-25.57%-33.34%
Net Margin Growth (1y) -10.64M
Net Margin (QoQ) -0.02M-8.06M
Operating Income Growth (1y) 9.39%-198.37%-27.67%
Operating Income (QoQ) 208.02%-201.47%30.53%-19.00%-17.27%-31.68%
Operating Margin Growth (1y) -10.93M
Operating Margin (QoQ) -0.02M-8.25M
Profit After Tax Growth (1y) -18.16%-186.88%-33.58%
Profit After Tax (QoQ) 270.79%-186.72%30.83%-15.34%-25.57%-33.34%
Property, Plant & Equipment (Net) Growth (1y) -5.29%-3.59%
Property, Plant & Equipment (Net) (QoQ) -3.48%3.69%-2.86%
Return on Assets (QoQ) -34.00-14.00
Return on Capital Employed (QoQ) -39.00-19.00
Return on Equity (QoQ) -39.00-19.00
Return on Invested Capital (QoQ) -38.00-20.00
Return on Sales Growth (1y) -0.11M
Return on Sales (QoQ) -220.00378.00-0.03M-0.08M
Revenue Growth (1y) -98.69%
Revenue (QoQ) -42.74%-66.67%
Share-based Compensation Growth (1y) -28.42%-52.19%-54.70%
Share-based Compensation (QoQ) 51.14%1.66%-30.71%-32.76%0.96%-3.68%
Shareholder's Equity Growth (1y) -14.13%-9.19%-35.42%
Shareholder's Equity (QoQ) -10.05%-13.94%-22.39%
Tax Rate Growth (1y) -18.00-63.009.00
Tax Rate (QoQ) 55.00-65.00-76.0068.0010.007.00